Asparaginase Erwinia chrysanthemi

DB08886ApprovedInvestigationalProtein Based TherapiesAsparagine-specific Enzyme

Asparaginase Erwinia chrysanthemi is an asparagine-specific enzyme used as part of a chemotherapeutic regimen to treat patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. It works by depleting the stores of an important amino acid called asparagine, which is involved in DNA synthesis and cell survival of malignant cells, leading to cell death.

Protein structure of Asparaginase Erwinia chrysanthemi
Mechanism
Curator reviewed · 4 references
Primary indication
Asparaginase Erwinia chrysanthemi is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma in adults and children who have developed hypersensitivity to...Curator reviewed · 2 structured indications
Formula / weight
C1546H2510N432O476S9 · 140000.0 Da
First approval
Canada, 2016 · United States, 2011 · European Union, 2023
Also known as
Asparaginase (Erwinia chrysanthemi) · Asparaginase (Erwinia) · Asparaginase Erwinia chrysanthemi (recombinant) · asparaginase erwinia chrysanthemi (recombinant)-rywn · Crisantaspase
Code names
JZP-458 · PF743
Brand names
  • Enrylaze
  • Erwinaze
  • Rylaze

Resolves to

Clinical / RWD

What you can answer from here — as of July 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
63Drug interactionsStructured to mechanism, not free text
Sign in
44Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4ContraindicationsEach with its own population and attribute set
Sign in
5Marketed productsAcross 3 countries and 2 labellers
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Asparaginase Erwinia chrysanthemi, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account